Kapil Cotex Ltd Quarterly Result

Kapil Cotex Ltd Quarterly Result

Image

Skybiotech Healthcare Limited

NSE: SKYBIOTECH

Net Profit - Last Quarter

₹ -0.3 Cr.

Last updated on: Jul 29, 2026

Skybiotech Healthcare Limited Quarterly Results Key Highlights

  • The revenue of Skybiotech Healthcare Limited for the Mar '26 is ₹ 1.98 crore as compare to the Dec '25 revenue of ₹ 1.04 crore.
  • This represent the growth of 90.38% The ebitda of Skybiotech Healthcare Limited for the Mar '26 is ₹ -0.73 crore as compare to the Dec '25 ebitda of ₹ -0.36 crore.
  • This represent the growth of 102.78% The net profit of Skybiotech Healthcare Limited for the Mar '26 is ₹ -0.3 crore as compare to the Dec '25 net profit of ₹ -0.48 crore.
  • This represent the decline of -37.5%.

Skybiotech Healthcare Limited Quarterly Results Analysis

Market Price of Skybiotech Healthcare Limited

1M

1Y

3Y

5Y

Monitoring Skybiotech Healthcare Limited share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Jul 2026169.95
28 Jul 2026167
27 Jul 2026168
24 Jul 2026160.15
23 Jul 2026157
22 Jul 2026149.85
21 Jul 2026142.75
20 Jul 2026136
17 Jul 2026130
16 Jul 2026136.8

Historical Revenue of Skybiotech Healthcare Limited

No data available

* All values are in crore

Historical EBITDA of Skybiotech Healthcare Limited

No data available

* All values are in crore

Historical Net Profit of Skybiotech Healthcare Limited

No data available

* All values are in crore

Skybiotech Healthcare Limited News Hub

Kapil Cotex reports standalone net profit of Rs 0.25 crore in the June 2024 quarter

Net profit of Kapil Cotex reported to Rs 0.25 crore in the quarter ended June 2024 as against net lo

Read more

16 Aug 24

Kapil Cotex to conduct AGM

Kapil Cotex announced that the 41th Annual General Meeting (AGM) of the company will be held on 30 S

Read more

18 Sept 24

Kapil Cotex announces board meeting date

Kapil Cotex will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powered

Read more

11 Nov 24

Kapil Cotex reports standalone net profit of Rs 0.01 crore in the September 2024 quarter

Net profit of Kapil Cotex remain constant at Rs 0.01 crore in the quarter ended September 2024 and a

Read more

15 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Skybiotech Healthcare Limited

  • Skybiotech Healthcare Limited was initially incorporated as Kapil Cotex Limited on October 14, 1983.
  • The Company has altered a change in name with due approval from the Registrar of Companies to Skybiotech Healthcare Limited in 2025. he Company is involved in Spinning, weaving and finishing of textiles. During the concerned year, it did not get any revenue from its main objects.
  • However, it gives consultancy & assistance in selling the goods of foreign clients & earned brokerage/consultancy income.
  • It also deals in shares & Securities, where it earned capital gains & dividend income. Company has acquired 72.52% stake in M/s.
  • Skybiotech Lifescience Private Limited, making it a subsidiary of the Company in 2024.

FAQs for Quarterly Results of Skybiotech Healthcare Limited

What key financial metrics are included in Skybiotech Healthcare Limited's quarterly results?

Key financial metrics in Skybiotech Healthcare Limited's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Skybiotech Healthcare Limited announce its quarterly results?

Skybiotech Healthcare Limited usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Skybiotech Healthcare Limited's quarterly performance impact its stock price?

Skybiotech Healthcare Limited's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Skybiotech Healthcare Limited's quarterly results on dividends?

The impact of Skybiotech Healthcare Limited's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Skybiotech Healthcare Limited's quarterly results?

Yes, Skybiotech Healthcare Limited often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions